WWW.PHARMAORG.COM WWW.PHARMAORG.COM: Any drug you wish to know about

NIZORAL       

      Nizoral is a medicine used for the treatment of systemic fungal infections or for other conditions determined by your physician. You should not use Nizoral Tablets for fungal meningitis.

How Taken
It is recommended that you use Nizoral once daily until the infection has disappeared. If the infection is serious, your doctor may increase the daily dosage.

Warnings/Precautions
You should report to your doctor any signs and symptoms which may indicate liver dysfunction so that appropriate biochemical testing can be done. Such signs and symptoms may include unusual fatigue, anorexia, nausea and/or vomiting, jaundice, dark urine or pale stools. Nizoral tablets may alter your metabolism.

Missed Dose
If you miss a dose, use it as soon as you remember. If it is near the time for the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.

Possible Side Effects
Stop taking this medicine and check with your doctor if any of these side effects occur: fever and chills; skin rash or itching; dark or amber urine; fever and sore throat; loss of appetite; pale stools; reddening.
Searching for something else? No problem!

Search for anything:

Implanted Nerve Stimulator Eases Epilepsy in Kids.
         Stimulation of a cranial nerve through an implant can effectively treat some children with epilepsy, according to the results of a new two-year study. In a study of more than 75 young patients, doctors found that 59 percent of those implanted with a vagus nerve stimulator did not suffer from localization-related epilepsy, or seizures occurring in one part of the brain. Hospital visits for epilepsy-related conditions also decreased by 41 percent, the researchers reported Wednesday at the International League Against Epilepsy Congress in Paris. The nerve stimulator is implanted in the left side of a patient's neck and works by sending signals to the brain to decrease the electrical activity that leads to seizures. It was approved by the U.S. Food and Drug Administration in 1997 for the treatment of epilepsy unresponsive to medication.
Main Page  Site Map